Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity
Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
Tags: AIDS, chronic Hepatitis B, HIV, nucleotide analog reverse-transcriptase inhibitor (NtRTI), tenofovir alafenamide prodrug, tenofovir disoproxil prodrug, Vemlidy®, Viread®
BASi Method Number SAP.752
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
